Richard Lowenthal

So, if you tell them, I prefer that 1, it's smaller, I can carry it.

I'm not afraid of the needle.

I'm going to use it very quickly when I have a reaction.

That's all the allergist needs to hear to be convinced that that's the right product for you.

So with that said, I mean, our wholesale price had to account for that copay assistance to buy down the copay.

Typically, you know, if it's a preferred product, the copay is going to be in the 25 to 40 range.

And if it's a non-preferred, it's probably in the 80 to 90 range.

on average.

And so we buy that down to zero and we price that into the wholesale price of the product.

So that and as I've just mentioned, the PBM costs, the rebates, the distributor costs is how we basically price the products so that we could retain enough of the net to cover our costs and repay our investors and cost of development.

We are lucky at ARS because we are not very affected by tariffs.

We manufacture NEFI in the United States.

We do have a couple of the components of NEFI that come from Europe.

But we source no ingredients of NEFI or the device from either Asia or India.

So nothing coming out of China or India.

And going back to Europe, we are selling NEFI in Europe now and Germany, UK.

It's been launched recently.

And there obviously is no tariff going back to Europe.

So we've actually are in fairly good shape with regards to the tariffs for NEFI itself because we manufacture the product in New Jersey.

We are setting up a second manufacturing site in the European region, which will eventually provide product for Europe.